XML 43 R31.htm IDEA: XBRL DOCUMENT v3.22.1
Basis of Presentation, Summary of Significant Accounting Policies and Change in Accounting Principles (Tables)
 3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Schedule of restricted cash and cash equivalents
Restricted cash and restricted investments include cash and investments used to collateralize various contractual obligations (in thousands) as follows:
March 31, 2022December 31, 2021
Collateral for letters of credit for facility leases (1)
$2,269 $3,769 
Collateral with financial institutions (2)
11,499 11,662 
Claims processing services (3)
38,855 73,226 
Other5 5 
Total restricted cash and restricted investments$52,628 $88,662 
Current restricted cash39,647 75,685 
Total current restricted cash and restricted investments$39,647 $75,685 
Non-current restricted cash12,981 12,977 
Total non-current restricted cash and restricted investments$12,981 $12,977 
————————
(1)Represents restricted cash related to collateral for letters of credit required in conjunction with lease agreements. See Note 12 for further discussion of our lease commitments.
(2)Represents collateral held with financial institutions for risk-sharing and other arrangements. As of March 31, 2022 and December 31, 2021, approximately $11.5 million and $11.7 million, respectively, of the collateral amounts were held in a FDIC participating bank account. See Note 17 for discussion of fair value measurement and Note 11 for discussion of our risk-sharing arrangements.
(3)Represents cash held by the Company related to claims processing services on behalf of partners. These are pass-through amounts and can fluctuate materially from period to period depending on the timing of when the claims are processed.

The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows (in thousands):
March 31,
20222021
Cash and cash equivalents$210,158 $236,032 
Restricted cash and restricted investments52,628 67,737 
Restricted investments included in restricted cash and restricted investments— — 
Total cash and cash equivalents and restricted cash shown in the consolidated statements of cash flows (1)
$262,786 $303,769 
————————
(1)As a result of the closing of the sale of True Health during the first quarter of 2021, the consolidated statement of operations and related financial information reflect the Company’s operations and assets and liabilities of True Health as discontinued operations. Cash flows and comprehensive income have not been adjusted and are included in the consolidated statements of cash flows and consolidated statements of comprehensive income (loss) for the three months ended March 31, 2021. See Note 5.
Schedule of cash and cash equivalents
The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the consolidated statements of cash flows (in thousands):
March 31,
20222021
Cash and cash equivalents$210,158 $236,032 
Restricted cash and restricted investments52,628 67,737 
Restricted investments included in restricted cash and restricted investments— — 
Total cash and cash equivalents and restricted cash shown in the consolidated statements of cash flows (1)
$262,786 $303,769 
————————
(1)As a result of the closing of the sale of True Health during the first quarter of 2021, the consolidated statement of operations and related financial information reflect the Company’s operations and assets and liabilities of True Health as discontinued operations. Cash flows and comprehensive income have not been adjusted and are included in the consolidated statements of cash flows and consolidated statements of comprehensive income (loss) for the three months ended March 31, 2021. See Note 5.
Schedule of intangible assets
The following summarizes the estimated useful lives by asset classification:
Corporate trade name
10 - 20 years
Customer relationships
10 - 25 years
Technology5 years
Provider network contracts
3 - 5 years
Details of our intangible assets (in thousands, except weighted-average useful lives) as of March 31, 2022 and December 31, 2021 are presented below:

March 31, 2022December 31, 2021
  Weighted- Average Remaining Useful LifeGross Carrying AmountAccumulated AmortizationNet Carrying ValueWeighted- Average Remaining Useful LifeGross Carrying AmountAccumulated AmortizationNet Carrying Value
Corporate trade name12.2$25,800 $8,079 $17,721 12.4$25,800 $7,693 $18,107 
Customer relationships14.7311,019 76,912 234,107 14.9311,019 72,697 238,322 
Technology1.787,922 75,254 12,668 2.087,922 73,378 14,544 
Below market lease, net1.11,218 1,000 218 1.31,218 950 268 
Provider network contracts (1)
1.916,236 8,737 7,499 2.216,417 7,874 8,543 
Total intangible assets, net$442,195 $169,982 $272,213 $442,376 $162,592 $279,784